Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
34.7 (1y: +153%)
Market Cap 1.16 B P/E(ttm)
Enterprise Value P/B
TSRO- NAS (USA)
Tesaro Inc
Not Rated
Top Ranked Predictable Companies
$34.70
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
» TSRO's 10-Y Financials

Financials


» Details

Guru Trades
Q2 2012

TSRO Guru Trades in Q2 2012

Paul Tudor Jones 25,000 sh (New)
» More
Q3 2012

TSRO Guru Trades in Q3 2012

Steven Cohen 100,000 sh (New)
Paul Tudor Jones Sold Out
» More
Q4 2012

TSRO Guru Trades in Q4 2012

Steven Cohen Sold Out
» More
Q1 2013

TSRO Guru Trades in Q1 2013

Jim Simons 28,178 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with TSRO



No Insider Trades Found!

Ratios

vs
industry		 vs
history
EV-to-EBIT 5
TSRO's EV-to-EBIT is ranked higher than
100% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: 14.61 vs. TSRO: 5 )
TSRO' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 5

Valuation & Return

vs
industry		 vs
history

Business Description

TESARO, Inc. was incorporated under the laws of the State of Delaware in March 2010. The Company is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. It has in-licensed and are currently developing two product candidates, rolapitant and TSR-011. It intends to continue to leverage the experience and competencies of its senior management team to identify, acquire, develop and commercialize cancer therapeutics and oncology supportive care products that are safer and more effective than existing treatments. The Company's product portfolio currently consists of two oncology-related product candidates: Rolapitant, a potent and long-acting neurokinin-1, or NK-1, receptor antagonist currently in Phase 3 clinical trials for the prevention of chemotherapy induced nausea and vomiting, or CINV; and TSR-011, an orally available anaplastic lymphoma kinase, or ALK, inhibitor (targeted anti-cancer agent) currently in preclinical development. It plans to test TSR-011 in clinical trials as a treatment for non-small cell lung cancer, or NSCLC, and potentially other cancer indications. OPKO had acquired certain NK-1 receptor related assets, including rolapitant, in 2010 from Schering-Plough Corporation, or Schering-Plough, as part of a United States Federal Trade Commission, or FTC, requirement to divest certain assets in connection with Schering-Plough's combination with Merck.
Company Website
SEC Reports
Industry: Biotechnology
Compare:
» More Articles for TSRO

Headlines

Articles On GuruFocus.com


Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK